Stockscreener 앱 받기
103.92
0.16%
0.17
시간 외 거래:
103.92
Exact Sciences Corp 주식(EXAS)의 최신 뉴스
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now - The Motley Fool
Exact Sciences Develops Home Colon Cancer Test Kit [da9403] - fathomjournal.org
Health care again among the state’s biggest M&A deals of the past yearBizTimes - BizTimes - Milwaukee Business News
EXACT Sciences Corp. Hits New 52-Week High at $104.00 - Markets Mojo
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026 - The Joplin Globe
EXACT Sciences Corp. Hits New 52-Week High at $103.92 - Markets Mojo
Wisconsin InnoExact Sciences' multi-cancer blood test | Curate acquired - The Business Journals
Exact Sciences (EXAS) merger with Abbott moving forward after shareholder approval - MSN
Jain Global LLC Purchases Shares of 481,607 Exact Sciences Corporation $EXAS - MarketBeat
EXAS Stock Price, Quote & Chart | EXACT SCIENCES CORP (NASDAQ:EXAS) - ChartMill
Exact Sciences Corp Stock (ISIN: US30063P1057) Attracts Major Investors Amid Cancer Screening Moment - AD HOC NEWS
Exact Sciences Corporation $EXAS Shares Purchased by EFG Asset Management Americas Corp. - MarketBeat
Privia Health Screening Program Increases Colorectal Cancer Screening Rates - MyChesCo
Mackenzie Financial Corp Has $150.11 Million Stake in Exact Sciences Corporation $EXAS - MarketBeat
Analysts Set Exact Sciences Corporation (NASDAQ:EXAS) Target Price at $92.13 - National Today
EXACT Sciences Corp. Hits New 52-Week High of $103.75 - Markets Mojo
Schroder Investment Management Boosts Stake in Exact Sciences - National Today
Capital World Investors Reduces Stake in Exact Sciences - National Today
Exact Sciences Case Study Links Higher Screening Rates With Undervalued Shares - Yahoo Finance
Exact Sciences stock hits 52-week high at 103.68 USD By Investing.com - Investing.com Canada
Exact Sciences stock hits 52-week high at 103.68 USD - Investing.com India
Exact Sciences EHR Outreach Program Highlights Cologuard Growth And Valuation Debate - simplywall.st
Evercore ISI Group downgrades Exact Sciences (EXAS) - MSN
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover - Stocktwits
Pentwater Capital Management LP's Exact Sciences Corp(EXAS) Holding History - GuruFocus
A Look At Exact Sciences (EXAS) Valuation After Strong 1 Year Shareholder Returns - simplywall.st
CSLLY or EXAS: Which Is the Better Value Stock Right Now? - Yahoo! Finance Canada
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year - BioSpace
EXACT SCIENCES CORP (NASDAQ:EXAS) Shows Strong Technical and Fundamental Momentum - ChartMill
Exact Sciences Stock: Is The Post-Earnings Slide A Buying Setup for 2026? - AD HOC NEWS
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - BioSpace
Exact Sciences (NASDAQ: EXAS) EVP exercises 3,900 options, 1,913 shares withheld - Stock Titan
Exact Sciences (EXAS) CEO reports RSU vesting and tax-withheld share dispositions - Stock Titan
KeyCare, Inc. announced that it has received $27.4 million in funding from a group of investors - marketscreener.com
Is Exact Sciences (EXAS) Pricing Reflect Long Term Cancer Screening Growth Potential - Yahoo Finance
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration – Company AnnouncementFT.com - Financial Times
Exact Sciences Corporation $EXAS Shares Sold by Fox Run Management L.L.C. - MarketBeat
EXAS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
[Form 4] EXACT SCIENCES CORP Insider Trading Activity - Stock Titan
EXACT Sciences (EXAS) HR EVP awarded 23,224 RSUs in new grant - Stock Titan
Exact Sciences (EXAS) grants SVP Herriott 20,321 restricted stock units - Stock Titan
EXACT Sciences (EXAS) CEO receives major RSU grant and tax-share withholding - Stock Titan
Exact Sciences (EXAS) awards 28,063 restricted stock units to EVP Baranick - Stock Titan
Exact Sciences (NASDAQ: EXAS) EVP receives 38,707 restricted stock units - Stock Titan
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval - Insider Monkey
December 18th Options Now Available For EXACT Sciences (EXAS) - Nasdaq
Market Outlook: Is Exact Sciences Corporation showing insider buyingJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Abbott Labs Increases Dividends for 54 Years, Acquires Exact Sciences - Intellectia AI
Abbott offers $20B in notes to finance Exact Sciences acquisition - MassDevice
Abbott Laboratories (ABT) sells $20B of notes to finance Exact Sciences acquisition - Stock Titan
Exact Sciences stock hits 52-week high at $103.55 By Investing.com - Investing.com India
Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal - Bloomberg
Abbott lines up one of the year's biggest bond sales at $20B - Crain's Chicago Business
Abbott Laboratories Stock (ABT) Opinions on Exact Sciences Acquisition - Quiver Quantitative
Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting - Yahoo Finance
Exact Sciences (NASDAQ:EXAS) Hits New 52-Week HighTime to Buy? - MarketBeat
Abbott kicks off bond sale for Exact Sciences deal - Modern Healthcare
Exact Sciences stock hits 52-week high at $103.55 - Investing.com
Abbott Laboratories Commences 8-Part Bond Sale Tied to Exact Sciences Acquisition, Bloomberg Reports - marketscreener.com
Exact Sciences shareholders approve merger with Abbott Laboratories By Investing.com - Investing.com Australia
0.55%
2.50%
자본화:
|
볼륨(24시간):